Logistic regression analysis of prognostic factors in 106 acute-on-chronic liver failure patients with hepatic encephalopathy

Cui YanPing; Liu FengHua; Shi QingFeng; Zhao HongKui; Wang SiKui

doi:10.3969/j.issn.1001-5256.2014.10.005

Issue 10

Oct. 2014

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2014 > 30(10): 992-995

PDF( 1348 KB)

Logistic regression analysis of prognostic factors in 106 acute-on-chronic liver failure patients with hepatic encephalopathy

DOI: 10.3969/j.issn.1001-5256.2014.10.005

Liaocheng People's Hospital

Received Date: 2014-01-17
Published Date: 2014-10-20

Abstract

Abstract

Objective To analyze the prognostic factors in acute-on-chronic liver failure ( ACLF) patients with hepatic encephalopathy ( HE) and to explore the risk factors for prognosis. Methods A retrospective analysis was performed on106 ACLF patients with HE who were hospitalized in our hospital from January 2010 to July 2013. The patients were divided into improved group and deteriorated group. The univariate indicators including age, sex, laboratory indicators [total bilirubin ( TBil) , albumin ( Alb) , alanine aminotransferase ( ALT) , aspartate amino-transferase ( AST) , and prothrombin time activity ( PTA) ], the stage of HE, complications [persistent hyponatremia, digestive tract bleeding, hepatorenal syndrome ( HRS) , ascites, infection, and spontaneous bacterial peritonitis ( SBP) ], and plasma exchange were analyzed by chi-square test or t-test. Indicators with statistical significance were subsequently analyzed by binary logistic regression. Results Univariate analysis showed that ALT ( P = 0. 009) , PTA ( P = 0. 043) , the stage of HE ( P = 0. 000) , and HRS ( P = 0. 003) were significantly different between the two groups, whereas differences in age, sex, TBil, Alb, AST, persistent hyponatremia, digestive tract bleeding, ascites, infection, SBP, and plasma exchange were not statistically significant ( P >0. 05) . Binary logistic regression demonstrated that PTA ( b =-0. 097, P =0. 025, OR =0. 908) , HRS ( b =2. 279, P =0. 007, OR =9. 764) , and the stage of HE ( b = 1. 873, P = 0. 000, OR = 6. 510) were prognostic factors in ACLF patients with HE. Conclusion The stage of HE, HRS, and PTA are independent influential factors for the prognosis in ACLF patients with HE. Reduced PTA, advanced HE stage, and the presence of HRS indicate worse prognosis.
- liver failure,
- hepatic encephalopathy,
- logistic models

FullText(HTML)

References(15)

References

[1] Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, MA;Severe Liver Diseases and Artificial Liver Group Chinese Society of Hepatology, MA.Guideline for diagnosis and treatment of liver failure (2012 version) [J].Chin J Clin Infect Dis, 2012, 12 (5) :321-326. (in Chinese) 中华医学会感染病学分会肝衰竭与人工肝治疗组、中华医学会肝病学分会重肝与人工肝学组.肝衰竭诊治指南 (2012年版) [J].中华临床感染病杂志, 2012, 12 (5) :321-326.

[2]Hepatic Encephalopathy Diagnosis and Treatment of the Expert Committee.Expert consensus on diagnosis and treatment of hepatic encephalopathy[J/CD].Chin J Exp Clin Infect Dis:Electronic Edition, 2009, 3 (4) :449-473. (in Chinese) 肝性脑病诊断治疗专家委员会.肝性脑病诊断治疗专家共识[J/CD].中华实验和临床感染病杂志:电子版, 2009, 3 (4) :449-473.

[3]FICHET J, MERCIER E, GENE O, et al.Prognosis and 1-year mortality of intensive care unit patients with severe hepatic encephalopathy[J].J Crit Care, 2009, 24 (3) :364-370.

[4]XIE SB, WU YK, ZHU JY, et al.Establishment and evaluation of prognosis scoring system for acute-on-chronic liver failure[J].J Sun Yat-sen univ:Medical Sciences, 2011, 32 (6) :834-840. (in Chinese) 谢仕斌, 吴元凯, 朱建芸, 等.慢加急性肝衰竭预后评分系统的建立与评估[J].中山大学学报:医学科学版, 2011, 32 (6) :834-840.

[5]LIU XY, CHEN J, WANG XX, et al.Etiological analysis of 3233patients with acute liver failure, subacute liver failure and acuteon-chronic liver failure[J].Clin Med Engineering, 2012, 19 (5) :823-825. (in Chinese) 刘晓燕, 陈婧, 王晓霞, 等.3233例急性、亚急性、慢加急性肝衰竭病因特点分析[J].临床医学工程, 2012, 19 (5) :823-825.

[6] LIU XY, HU JH, WANG HF, et al.Etiological analysis of 1977 patients with acute liver failure, subacute liver failure and acute-onchronic liver failure[J].Chin J Hepatol, 2008, 16 (10) :772-775. (in Chinese) 刘晓燕, 胡瑾华, 王慧芬, 等.1977例急性、亚急性、慢加急性肝衰竭患者的病因与转归分析[J].中华肝脏病杂志, 2008, 16 (10) :772-775.

[7]ZENG Z, LOU M, CHANG XJ, et al.Clinical characteristics and prognosis of four types of liver failure[J].Infect Dis Info, 2008, 21 (6) :353-354. (in Chinese) 曾珍, 楼敏, 常秀娟, 等.四类肝衰竭的临床特点与转归分析[J].传染病信息, 2008, 21 (6) :353-354.

[8]YU YH, JIANG JN, WU JZ, et al.Logistic regression analysis of prognostic factors for hepatic encephalopathy[J].Chin J Infect Dis, 2009, 27 (5) :305-307. (in Chinese) 玉艳红, 江建宁, 吴继周, 等.肝性脑病患者预后影响因素的Logistic回归分析[J].中华传染病杂志, 2009, 27 (5) :305-307.

[9]TAO C, YUAN CB, ZENG WQ, et al.Analysis of causes of death in 72 patients with chronic severe hepatitis[J].Chin J Primary Med Pharm, 2008, 15 (9) :1497-1498. (in Chinese) 陶晨, 袁春蓓, 曾文权, 等.慢性重型肝炎72例死亡原因分析[J].中国基层医药, 2008, 15 (9) :1497-1498.

[10]YE PY, YANG ZG, CHEN XR, et al.Risk factors associated with prognosis of progressive stages of acute-on-chronic hepatitis B liver failure[J].J Clin Hepatol, 2013, 29 (4) :270-275. (in Chinese) 叶佩燕, 杨宗国, 陈晓蓉, 等.HBV相关慢加急性肝衰竭不同分期的预后评价及影响因素分析[J].临床肝胆病杂志, 2013, 29 (4) :270-275.

[11]YANG B, WU YK, CHEN ZC, et al.The dynamic changes of ALT, AST, TBil and PT and their relationship with prognosis of acute-on-chronic hepatitis B liver failure[J].J Clin Hepatol, 2012, 28 (3) :205-208. (in Chinese) 杨波, 吴元凯, 陈忠诚, 等.ALT、AST、TBil及PT变化趋势与慢加急性乙型肝炎肝衰竭预后的关系[J].临床肝胆病杂志, 2012, 28 (3) :205-208.

[12] LIU XY, HU JH, WANG HF, et al.Analysis of prognostic factors for patients with acute-on-chronic liver failure[J].Chin J Hepatol, 2009, 17 (8) :607-610. (in Chinese) 刘晓燕, 胡瑾华, 王慧芬, 等.乙型肝炎病毒感染所致慢加急肝衰竭的临床预后分析[J].中华肝脏病杂志, 2009, 17 (8) :607-610.

[13]LAI N, GUO SH, ZHANG DZ, et al.A single factor analysis of the prognosis of 301 hepatitis failure cases and a study of a scoring system on their prognostic assessment[J].Chin J Hepatol, 2005, 13 (8) :586-589. (in Chinese) 赖宁, 郭树华, 张大志, 等.重型肝炎预后单因素分析与预后评估系统研究[J].中华肝脏病杂志, 2005, 13 (8) :586-589.

[14]SUN LH, ZHANG YX, XIAO L, et al.Analysis of the prognosis of severe hepatitis treated with molecular adsorbent recycling system (MARS) using MELD score[J].Chin J Hepatol, 2005, 13 (8) :632-635. (in Chinese) 孙丽华, 张跃新, 肖琳, 等.终末期肝病评分模型评价分子吸附再循环系统治疗重型肝炎的疗效和预后[J].中华肝脏病杂志, 2005, 13 (8) :632-635.

[15]LIAO JM, LI ZR, HU XX.The therapeutic effect of plasma exchange therapy in patients with severe hepatitis[J].J Clin Hepatol, 2012, 28 (4) :302-304. (in Chinese) 廖金卯, 李灼日, 胡小宣.人工肝血浆置换治疗重型肝炎的疗效观察[J].临床肝胆病杂志, 2012, 28 (4) :302-304.

Relative Articles

[1]	Yuanqin DU, Meng WANG, Guochu HUANG, Chun YAO, Ruixi ZHONG, Liangjiang HUANG, Jian XU, Jingjing HUANG, Qinwen TAN, Dewen MAO. Therapeutic effect of retention enema with compound rhubarb decoction on a rat model of minimal hepatic encephalopathy based on bile acid metabolomics[J]. Journal of Clinical Hepatology, 2023, 39(10): 2348-2357. doi: 10.3969/j.issn.1001-5256.2023.10.012
[2]	Yebei LIANG, Chunguang YANG, Huadong ZENG, Ruwei TAO, Qiuming HU, Xiaoying TANG, Huaxiang SHI, Wei WU, Xuhong HOU, Weiping JIA. Establishment of screening models for nonalcoholic fatty liver disease in the adult Blang population[J]. Journal of Clinical Hepatology, 2021, 37(12): 2861-2868. doi: 10.3969/j.issn.1001-5256.2021.12.025
[3]	Ruan JingSheng, Chen Chuang, Li KeZhi, Huang Shan, He JianBo, Ceng AiPing, Lian Fang, Wu GuoBin. Expression and significance of semaphorin 3A and its receptor NRP-1 in a rat model of chronic hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2020, 36(6): 1334-1341. doi: 10.3969/j.issn.1001-5256.2020.06.029
[4]	Lin DongYi, Peng Bo, Zheng JingHui, Wang ZongYu, Li HanZhong, He JianBo, Li KeZhi, Wu GuoBin, Chen Chuang. Value of a logistic regression model based on the clinical features of liver cancer in judging the traditional Chinese medicine syndrome types of primary liver cancer[J]. Journal of Clinical Hepatology, 2020, 36(6): 1293-1298. doi: 10.3969/j.issn.1001-5256.2020.06.021
[5]	Gong Man, Zhou Chao, Zhang Ning, Sun KeWei, Zhang ZhenGang, Li HanMin, Li XiuHui, Yang HongZhi, Li Qin, Wang Lin, Zhou XiaoZhou, Mao DeWen, Guo JianChun, Zhuo YunHui, Wang XianBo, Deng Xin, Wang JieFei, Cao WuKui, Zhang ShuQin, Zhang MingXiang, Li Yun. Clinical effect of integrated traditional Chinese and Western medicine therapy in patients with hepatitis B virus-related acute-on-chronic liver failure complicated by hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2018, 34(4): 795-800. doi: 10.3969/j.issn.1001-5256.2018.04.020
[6]	Wang FengJiao, Liu MingJiang, Wu RuiHong, Niu JunQi. A multivariate logistic regression analysis of short-term prognosis of patients with hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2017, 33(4): 711-714. doi: 10.3969/j.issn.1001-5256.2017.04.022
[7]	Hu LiHua, Chen Peng, Wang XiaoLi, Zhang JiYe, Su LianMing, Zhang PeiYi. Relationship between zonula occludens-1 and blood-brain barrier permeability in rats with hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2015, 31(4): 582-584. doi: 10.3969/j.issn.1001-5256.2015.04.025
[8]	Gu LiLi, Wang XianBo. Research progress in noninvasive regression models for liver fibrosis in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2014, 30(7): 691-694. doi: 10.3969/j.issn.1001-5256.2014.07.032
[9]	Wang GuangYi, Shi XiaoJu, Jiang Chao, Sun XiaoDong, Qiu Wei, Lu: GuoYue. One case of liver transplantation for liver failure due to adult- onset Still's disease[J]. Journal of Clinical Hepatology, 2014, 30(1): 67-68. doi: 10.3969/j.issn.1001-5256.2014.01.018
[10]	Gao Rui, Liu ZhongJing, Chen Fei, Gao Lei, Jiang ChuanWu. Multivariate regression analysis of risk factors for HBV-related primary liver cancer[J]. Journal of Clinical Hepatology, 2014, 30(4): 370-372. doi: 10.3969/j.issn.1001-5256.2014.04.021
[11]	Zhang ZhanQing, Lu Wei, Wang YanBing, Jia XiaoFang, Zhang LiJun, Ding RongRong, Zhou XinLan, Feng YanLing. Diagnosis of hepatic fibrosis in hepatitis B patients by logistic regression modeling based on plasma amino acid ratio and age[J]. Journal of Clinical Hepatology, 2013, 29(5): 330-335.
[12]	Zhang WenHua, Jia WenLing, Zhou ZiYing, Tang HaiTao, Wang FengMei. Investigation on the method and safety of the non-heparinized plasma exchange therapy in treating patients with hepatic failure[J]. Journal of Clinical Hepatology, 2012, 28(1): 50-52.
[13]	Zhou XinMin, Dong XuYang. Therapeutic strategies of liver failure for clinical cases[J]. Journal of Clinical Hepatology, 2012, 28(2): 93-98.
[14]	Zhang AiMin, Xin ShaoJie. Virus infection and liver failure[J]. Journal of Clinical Hepatology, 2012, 28(10): 729-731.
[15]	Xu DaHai, Zhang Nan, Gao JinYing, Wu Yang. The therapeutic development of hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2011, 27(2): 218-221.
[16]	Jiang Hao, Xie Qing. Advances in the diagnosis and treatment of hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2011, 27(10): 1027-1031.
[17]	Wang YuMing, Yan ZeHui. The new concepts on hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2010, 26(6): 568-574.
[18]	Li ShuangXing, Shi LiJun, Wang XiuJie. Effects of bone marrow mesenchymal stem cells transplantation into rats with acute liver failure[J]. Journal of Clinical Hepatology, 2010, 26(6): 624-626.
[19]	Liang Jing, Kan ZhiChao, Zhang JianDong. The clinical characteristics and treatment of liver failure patients with spontaneous bacterial peritonitis[J]. Journal of Clinical Hepatology, 2010, 26(6): 621-623.

Supplements(0)

Cited By

Cited by

Periodical cited type(25)

1.	陈炜. 终末期肝病模型联合血清钠评分对肝衰竭患者短期预后的预测价值. 川北医学院学报. 2024(02): 247-251 .
2.	王学英. MELD-Na评分联合NLR预测肝硬化食管胃静脉曲张破裂出血后再出血的临床价值. 罕少疾病杂志. 2024(05): 70-72 .
3.	林小洪，吴文楠，荀振. 血小板-白蛋白-胆红素评分与肝硬化患者肝功能Child-Turcotte-Pugh分级的相关性分析. 福建医科大学学报. 2024(01): 37-43 .
4.	孙玉，秦维，王丹，郑艳丽，霍玉玲. 前白蛋白及纤维蛋白原水平与代偿期肝硬化食管静脉曲张发生的关系. 中国肝脏病杂志(电子版). 2024(02): 7-12 .
5.	石红. 延续性护理服务方案对肝硬化食管胃静脉曲张内镜下精准断流术后的临床影响研究. 基层医学论坛. 2024(20): 114-116+142 .
6.	李欣忆，李娇娇，孙蔚. 肝硬化食管胃底静脉曲张破裂出血患者经颈静脉肝内门体分流术后发生显性肝性脑病的列线图预测模型建立及评价. 临床肝胆病杂志. 2024(08): 1605-1611 . 本站查看
7.	杨丹，周健. 多种无创预测模型在肝硬化门静脉高压中的研究进展. 中国临床研究. 2024(11): 1778-1783 .
8.	陈刚，谷光丽，何映雪，唐尧. 血清表皮生长因子对肝硬化食管胃静脉曲张患者再出血的诊断价值分析. 转化医学杂志. 2024(10): 1698-1702 .
9.	喻雪珂，黎孟玲，彭思远，申月明，梁纶熙，曾亚. 食管胃底静脉曲张破裂出血对肝硬化患者1年死亡结局的影响及相关因素研究. 中国全科医学. 2023(14): 1745-1752 .
10.	郝艳萍，韩靓，仇晶辉，滕圣智，王建华. 乙肝肝硬化食管胃静脉曲张急性出血患者内镜下治疗后发生菌血症的危险因素分析. 中国消毒学杂志. 2023(03): 182-184 .
11.	顾达，童聪，赵祥安，向晓星. PC/SD、FIB-4指数、CTP评分、MELD评分、MELD-Na评分在预测肝硬化食管静脉曲张出血套扎术后1年内再出血的价值评估. 胃肠病学和肝病学杂志. 2023(03): 289-294 .
12.	朱会明，张华，张金荣，吴雪华，吴柳，刘义安. 肝硬化血瘀证患者食管胃底静脉曲张相关性研究. 中国中医急症. 2023(04): 665-668 .
13.	周苏云，周影，程新月. 肝硬化患者发生肝性脑病的影响因素分析及对预检分诊意义的探讨. 中西医结合护理(中英文). 2023(03): 130-132 .
14.	葛琴. 血府逐瘀汤联合双歧杆菌三联活菌治疗酒精性肝硬化的疗效研究. 中医临床研究. 2023(20): 142-145 .
15.	邱荣金，卢劲瑜，苏雪梅，郑凤祥，廖丽芳. 预防使用抗生素对食管胃静脉曲张内镜下治疗的影响评估. 中国现代药物应用. 2023(19): 99-101 .
16.	邢恩涛，赵孟杰，金鹏飞，武振东，刘志春. 肝硬化门静脉高压TIPS术后HVPG下降相关因素. 青岛大学学报(医学版). 2023(05): 759-762 .
17.	刘媛，徐建光，何雪云，万秀萍，林小花，王莉娟，郑临海. 血钙浓度联合MELD评分对肝硬化严重程度的预测价值. 浙江中西医结合杂志. 2022(02): 129-130+149 .
18.	张春燕，田正方，朱经科，晁燕茹. 肝硬化患者食管静脉曲张套扎术后再出血影响因素分析及干预对策. 黑龙江医药科学. 2022(02): 96-99 .
19.	俞斌，屠军，沈玉玲. AIMS65评分预测肝硬化食管胃底静脉曲张破裂出血患者死亡的价值. 胃肠病学和肝病学杂志. 2022(07): 737-742 .
20.	刘益，周自忠，刘刚，徐海荣. 食管胃底静脉曲张破裂出血患者急诊TIPS术后肝性脑病发生特征及危险因素分析. 肝脏. 2022(06): 658-661 .
21.	廖翔. 肝硬化患者SAAG与食管胃底静脉曲张破裂出血的关系研究. 现代诊断与治疗. 2022(11): 1646-1648+1692 .
22.	张春燕，田正方，朱经科，晁燕茹. 肝硬化患者食管静脉曲张套扎术后再出血影响因素分析. 黑龙江医药科学. 2022(05): 171-173 .
23.	曾伍姣，张知洪，陈令民，李亦明. 血管紧张素Ⅱ水平在肝硬化患者诊断中的应用及与MELD评分关系研究. 肝胆外科杂志. 2021(01): 60-63 .
24.	祝强，杨继敏，刘中亮. 八种评分系统对肝硬化失代偿期患者短期预后的预测价值. 中国医药科学. 2021(19): 18-22 .
25.	赵媛，赵明，范玉梅，邵建营. 失代偿期乙型肝炎肝硬化患者不同病毒学应答状态对生存率及肝癌患病率的影响. 中国实用医刊. 2020(23): 50-52 .

Other cited types(9)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (3005) PDF downloads(683)

Logistic regression analysis of prognostic factors in 106 acute-on-chronic liver failure patients with hepatic encephalopathy

DOI: 10.3969/j.issn.1001-5256.2014.10.005